The FDA is cracking down on the use of ephedra, a substance that has been linked to heart attacks, strokes and seizures. 
 The agency wants to ban the substance because it contains a natural form of a key chemical in the cholesterol-lowering prescription drug Mevacor. 
 Last month, a judge issued a preliminary injunction lifting the FDA's administrative ban of Cholestin. 
 The company contends that the product is a natural alternative for people who are too healthy to take the drug. 
 The FDA wants to ban the substance because it contains a natural form of a key chemical in the cholesterol-lowering prescription drug Mevacor.